Description
Nuclear Medicine in Oncology, 1st ed. 2019
Molecular Imaging and Target Therapy
Language: EnglishSubject for Nuclear Medicine in Oncology:
Publication date: 11-2020
346 p. · 21x27.9 cm · Paperback
Publication date: 10-2019
346 p. · 21x27.9 cm · Hardback
Description
/li>Contents
/li>Biography
/li>Comment
/li>
This book is a useful reference for professionals engaged in nuclear medicine and clinical research, including clinical nuclear medicine physicians, nuclear medicine engineers and nuclear medicine pharmacists.
1. Glucose Metabolism Imaging.- 2. Clinical Utility of 18F-FDG PET/CT in Breast Cancer Management and Targeted Therapy.- 3. The application of 18F-FDG PET/CT in diagnose and therapy of non-small cell lung cancer.- 4. Clinical application of 18F-FDG PET/CT in lymphoma.- 5. Clinical utility of 18F-FDG PET/CT scanning in urological cancers management.- 6. Gynecologic tumor PET / CT imaging .- 7. Molecular imaging and targeted therapy of gastrointestinal cancer.- 8. Head and Neck Cancer.- 9. Molecular imaging and targeted therapy of malignant melanoma.- 10. Role of 18F-FDG PET/CT in Pediatric Oncology.- 11. Molecular imaging.- 12. Receptor targeted radionuclide imaging (RTRI) and peptide receptor radionuclide therapy (PRRT).- 13. Radioimmunoimaging and targeted therapy.- 14. Apoptosis imaging.- 15. Radionuclide gene and reporter gene imaging.- 16. Na+/I− symporter target for thyroid disease imaging and treatment.- 17. Molecular Imaging and Targeted Therapy In Neurology.- 18. Nuclear cardiolgy .- 19. Equipment for imaging and mechanism, radiation protection.- 20. Molecular imaging probe.
Editor Gang Huang is a professor and the President, Shanghai University of Medicine & Health Sciences(SUMHS). He is also the Elected President of Asia-Oceanian Federation of Nuclear Medicine &Biology; Dean of Asia School of Nuclear Medicine; Editor in Chief, Chinese Journal of Nuclear Medicine & Molecular Imaging andt the predecessor president of Chinese Society of Nuclear Medicine.
These books may interest you
Radiopharmaceuticals for Therapy 137.14 €